Schedule 13G ownership disclosure

REVANCE THERAPEUTICS INC

Common Stock · CUSIP: 761330109

Event date: 2024-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Patrick Lee, MD

    Shares: 1,611,787.00 · Class: 1.54%

  • Anthony Joonkyoo Yun, MD

    Shares: 1,611,787.00 · Class: 1.54%

  • Palo Alto Investors LP

    Shares: 1,611,787.00 · Class: 1.54%

  • PAI LLC

    Shares: 1,611,787.00 · Class: 1.54%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001306923-25-000009
Form type
SCHEDULE 13G/A
Filer
Palo Alto Investors LP
CIK
CIK 1306923
Filed
Feb 13, 2025
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub